http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011142829-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2011142829-A
titleOfInvention MATRIX TYPE PRODUCT WITH PROLONGED RELEASE CONTAINING A BASIC ADDITIVE
abstract 1. A sustained release matrix type preparation in which the carbonitrile derivative of N-acylpyrrolidine having an amino group in its molecule is stabilized, said preparation containing a normal base salt, which is hardly soluble in water, and also an excipient. 2. Sustained-release matrix-type preparation according to claim 1, characterized in that the carbonitrile derivative of N-acylpyrrolidine having an amino group in its molecule is vildagliptin, saxagliptin, melogliptin, denagliptin, TS-021, MP-513 or a carboxamide derivative of aminoacetinp represented by the general formula (1) (In the general formula (I): A represents CH, CHF or CF; R represents a hydrogen atom, a C1-C6 alkyl group which may be substituted, a C3-C8 cycloalkyl group which may be substituted , an arylmethyl group which may be substituted, an aryl ethyl group which may be substituted, an aromatic hydrocarbon group which may be substituted, an aromatic heterocycle which may be substituted or an aliphatic heterocycle which may be substituted; and n is 1 or 2). 3. Sustained-release matrix type preparation according to claim 1, characterized in that said carbonitrile derivative of N-acylpyrrolidine having an amino group in its molecule is vildagliptin, saxagliptin, melogliptin, denagliptin, TS-021, MP-513 or (28 48) -1- [N- (4-ethoxycarbonylbicyclo [2.2.2] oct-1-yl) amino] acetyl-4-fluoro-pyrrolidine-2-carbonitrile. 4. Sustained-release matrix-type preparation according to any one of claims 1 to 3, characterized in that said basic difficulty
priorityDate 2009-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11235729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426170728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421332523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11077541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11205761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421437236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426151525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11623906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 42.